Morgan & Morgan Reminds Investors That a Class Action

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against iDreamSky Technology Limited and Lead Plaintiff Deadline of June 1, 2015 -- DSKY

NEW YORK, April 29, 2015 (GLOBE NEWSWIRE) -- Morgan & Morgan, P.C. reminds investors that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities that purchased the American Depository Shares ("ADSs") of iDreamSky Technology Limited ("iDreamSky" or the "Company") (Nasdaq: DSKY ) between August 8, 2014 and March 13, 2015, inclusive, including those investors who acquired iDreamSky ADSs pursuant or traceable to its initial public offering ("IPO") commenced on or about August 7, 2014 (collectively, the "Class Period") alleging violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 against the Company and certain of its officers (the "Complaint").

If you purchased iDreamSky during the Class Period, you may, no later than June 1, 2015, request that the Court appoint you lead plaintiff of the proposed class. A lead plaintiff is a representative party that acts on behalf of all class members in directing the litigation. Any member of the purported class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

If you want more information about the iDreamSky Class Action , contact Morgan & Morgan at 1(800) 732-5200 or email info@morgansecuritieslaw.com

iDreamSky licenses and operates single player mobile games and mobile online games in the People's Republic of China.

The Complaint alleges that iDreamSky made materially false and misleading statements and failed to disclose material adverse facts about its business, operations, prospects, and performance. Specifically, the complaint alleges that iDreamSky failed to disclose that the company had overstated its ability to monetize its user base and effectively integrate its distribution channels. On March 13, 2015, after the market closed, iDreamSky lowered its revenue guidance for fourth quarter 2014 approximately by $9.9 million USD to approximately $53 million USD. According to the company, the revision of fourth quarter guidance is the result of the delay of a popular game, launched on one of the company's distribution platforms, and lower than anticipated revenues from another game being launched simultaneously as other hit games on the same distribution platform.

Following this news, American Depositary Shares of iDreamSky fell $3.60, or over 33%, to close at $7.22 per share.

About Morgan & Morgan

Morgan & Morgan is one of the nation's largest 200 law firms. In addition to shareholder rights, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability. All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people."

Attorney advertising. Prior results do not guarantee a similar outcome.

Morgan & Morgan Peter Safirstein, Esq. 28 West 44th Street Suite 2001 New York, NY 10036 1-800-732-5200

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

HKUST Strengthens Global Innovation Ties with Sweden

Updated Category News Views 285

HKUST Strengthens Global Innovation Ties with Sweden A high-level delegation from The Hong Kong University of Science and Technology (HKUST), led by President Professor Nancy Ip, recently completed a strategic visit to Sweden. This initiative aims to form deeper partnerships with prominent academic and research institutions in the country. Through this visit, Hong Kong...

Continue Reading
Foundation Fighting Blindness Enhances Donation Options for All

Updated Category News Views 210

Foundation Fighting Blindness Expands Donation Options The Foundation Fighting Blindness is leading the way in innovative methods for supporting research on treatments and cures for blinding diseases. Recently, the foundation has made substantial enhancements to its donation platforms, giving potential contributors more flexible options. In partnership with The Giving...

Continue Reading
Unveiling United Therapeutics: Insights on Upcoming Earnings

Updated Category News Views 190

United Therapeutics: Preparing for Quarterly Earnings United Therapeutics (NASDAQ: UTHR) is gearing up to release its latest quarterly earnings report. Investors are keenly awaiting this announcement, which comes on the heels of their last report. Analysts are projecting an earnings per share (EPS) of $6.93 for this upcoming quarter, which has set expectations high among...

Continue Reading
Sonder Holdings Welcomes Erin Wallace to Its Board Leadership

Updated Category News Views 410

Erin Wallace Joins Sonder Holdings Board of Directors Sonder Holdings Inc. recently made headlines as it appointed Erin Wallace to its Board of Directors. This exciting news marks a significant transition for the company, particularly in strengthening its leadership team. With her extensive background and expertise, Erin is set to make an immediate impact. A Shift in...

Continue Reading
Key Outcomes from Agfa-Gevaert NV's Special General Meeting

Updated Category News Views 149

Key Decisions at Agfa-Gevaert NV's Special General Meeting On an important Friday, Agfa-Gevaert NV convened for a Special General Meeting. Here, shareholders gathered to approve significant changes that shape the company's future direction. A notable highlight of the meeting was the endorsement of MJP Management Services BV, with Mr. Michel Govaert appointed as an...

Continue Reading